← Eichor
Study identifier: NCT06720142 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mg OSTEOCRETE Post-Treatment Outcomes

Condition: Cancer of Bone · Trauma · Aseptic Loosening of Orthopaedic Hardware  ·  Sponsor: Santiago Lozano-Calderon

PhaseN/A
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Shreya Halur, BS  ·  617-726-4932  ·  shalur@mgh.harvard.edu

Santiago A Lozano-Calderon, MD, PhD  ·  617-643-4947

Always discuss trial participation with your own doctor first.

Locations (1)

Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06720142